Testosterone products: increased risk of CV disorders

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1588卷 / 1期

关键词：

D O I：

10.1007/s40278-016-14595-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[1] Testosterone therapy: increased risk of CV events
Reactions Weekly, 2014, 1489 (1) : 2 - 2
[2] Testosterone products: increased risk of stroke and MI?
Reactions Weekly, 2015, 1543 (1) : 6 - 6
[3] Testosterone therapy in men not linked to increased CV risks?
Reactions Weekly, 2015, 1542 (1) : 13 - 13
[4] New evidence of CV risk with testosterone therapy
Reactions Weekly, 2014, 1484 (1) : 3 - 3
[5] Testosterone: no increased risk of atherosclerosis
Reactions Weekly, 2015, 1568 (1) : 12 - 12
[6] Increased CV risk with rosiglitazone but not pioglitazone
Reactions Weekly, 2009, 1276 (1) : 2 - 2
[7] Celecoxib: no increased risk of CV events
Reactions Weekly, 2002, 892 (1) : 4 - 4
[8] Risk of CV disorders with insulin or sulfonylureas
Reactions Weekly, 2008, 1222 (1) : 3 - 3
[9] Increased CV risk with glucocorticoids in Cushing's
Reactions Weekly, 2012, 1413 (1) : 1 - 1
[10] No increased CV risk with systemic psoriasis therapies?
Reactions Weekly, 2011, 1367 (1) : 3 - 3

← 1 2 3 4 5 →